Carolyn Shelton - Dec 31, 2024 Form 5 Insider Report for Nexalin Technology, Inc. (NXL)

Role: Senior VP
Signature: /s/ Carolyn Shelton Name: Carolyn Shelton
Stock symbol: NXL
Transactions as of: Dec 31, 2024
Transactions value $: $20,400
Form type: 5
Date filed: 2/10/2025, 06:21 PM
Next filing: Mar 13, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NXL	Common stock	Purchase	$20.4K	+24K		$0.85	24K	Oct 14, 2024	Direct	F1
holding	NXL	Common stock						24K	Dec 31, 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NXL	Stock Option (right to buy)	Award	$0	+90.6K		$0.00	90.6K	Nov 7, 2024	Common Stock	90.6K	$0.66	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares purchased after appointment as Senior Vice President, Quality, Regulatory and Clinical Affairs.
F2	The reporting person was granted an option to purchase 90,620 shares of common stock. The option vests in three equal annual installments based on the satisfaction of certain performance criteria for each of the annual periods ending September 16, 2025, 2026 and 2027.